«After two and a half years of arbitration proceedings concerning BESREMi® (Ropeginterferon alfa-2b), the decision by the ICC Arbitral Tribunal has now been made. In 2017 PharmaEssentia had attempted to terminate the contractual agreement with AOP Orphan. The arbitral award states that the termination of the aforementioned contract was unjustified and thus that the license agreement remains in full force and effect. Consequently, AOP Orphan is entitled to payment of damages for project delays caused by PharmaEssentia, resulting in delays of the approval of the medicinal product for human use BESREMi® in Europe and delays in supply to patients affected by polycythaemia vera. On these grounds, the ICC has awarded AOP Orphan damages of a total of approximately EUR 143 million. »
ICC ruled in favor of AOP Orphan Pharmaceuticals... - MPN Voice
ICC ruled in favor of AOP Orphan Pharmaceuticals AG in arbitration proceedings pertaining to BESREMi®
Written by
Manouche
To view profiles and participate in discussions please or .
2 Replies
•
MazcdPartnerMPNVoice
important to note that drug BESREMI is approved in the EU. MPN voice has no specific additional comment
Not what you're looking for?
You may also like...
European Besremi legal tussle continues
this week set aside the €143 million (US$162.8 million) in damages awarded to AOP, citing...
AOP Orphan announces 5-year results on BESREMi® in PV at the ASH Annual Meeting 2020
https://edomexaldia.com/2020/12/06/aop-orphan-announces-5-year-results-on-besremi-ropeginterferon-al
PEGASYS and Besremi Site injection pain
again during me second dose. There was a 2 day delay and then redness, tenderness and extreme pain....
Anyone else experience worse side effects on Besremi as compared to Pegasys?
after injecting. In January 2022 I switched to Besremi and used a 150 mcg dose every 2 weeks....
Emergency Room Visit: Besremi and Afib?
heart. I workout, and have passed stress tests.
Besremi can cause afib according to the warnings....